please supply a category in the pcf properties

Research

TTUHSC Receives NIH Grant to Examine Impact of Vitamin A Depletion on Alzheimer’s Disease

  • By Mark Hendricks
  • March 21, 2022

To gain insight into the potential relationship between ROS accumulation in the dentate gyrus and the onset of Alzheimer’s disease, the National Institutes of Health recently awarded a five-year, $1.87 million grant to TTUHSC's J. Josh Lawrence, Ph.D.

Research

Texas Tech University Health Sciences Center Researchers Achieve Global Recognition

  • By Senior Vice President for Research and Innovation Lance McMahon, Ph.D.
  • March 08, 2022

The global preeminence of TTUHSC is highlighted by a widely publicized citation database created at Stanford University. The comprehensive database shows that TTUHSC is the academic home to several of the world’s top-ranked biomedical and pharmaceutical researchers.

Research

TTUHSC’s Rahman Receives Grant Extension

  • By Mark Hendricks
  • March 04, 2022

In its most recent funding cycle, the Cancer Prevention & Research Institute of Texas (CPRIT) awarded a $2,499,999 grant extension to Rakhshanda Rahman, M.D., professor of breast surgical oncology at the Texas Tech University Health Sciences Center School of Medicine and the founding executive director of the school’s multi-campus Breast Center of Excellence (BCE).

TTUHSC’s Jansen Receives NIH Grant to Continue Study into Neurological Disorders

  • By Mark Hendricks
  • February 22, 2022

To continue her research, the National Institute of Neurological Disorders and Stroke (NINDS) at the National Institutes for Health (NIH) recently awarded Michaela Jansen, Pharm.D., Ph.D., a four-year, $1.53 million grant.

Research

NIH Awards Grant to TTUHSC Researcher

  • By Mark Hendricks
  • February 01, 2022

To better understand the role of extracellular vesicles in the spread and progression of LAM, the NIH recently awarded a four-year, $2.8 million grant to Magdalena Karbowniczek, M.D., Ph.D., a professor of immunotherapeutics and biotechnology at the TTUHSC Jerry H. Hodge School of Pharmacy.

Research

TTUHSC Researchers Receive New NIH Grant to Continue Studying Amygdala-Pain Link

  • By Mark Hendricks
  • January 31, 2022

The National Institutes of Health (NIH) recently awarded a five-year, $2.76 million grant to Volker E. Neugebauer, M.D., Ph.D. and Igor Ponomarev, Ph.D.

TTUHSC Scientist Seeking Solution to Antibiotic Resistance

  • By Mark Hendricks
  • January 19, 2022

A team of researchers led by Hongjun (Henry) Liang, Ph.D., from the Texas Tech University Health Sciences Center (TTUHSC) Department of Cell Physiology and Molecular Biophysics, recently investigated whether or not a series of novel nanoparticles can kill some of the pathogens that lead to human infection without affecting healthy cells.

Research

TTUHSC Researchers Receive Patent for Identifying Viable Embryos

  • By Mark Hendricks
  • December 02, 2021

The Texas Tech Office of Research Commercialization (ORC) filed an initial U.S. patent application in 2016, and a patent was awarded to Prien and Penrose on Nov. 8, 2021.

TTUHSC Researcher Investigates Ways to Enhance Neurolysin Activity in the Brain

  • By Mark Hendricks
  • October 07, 2021

Vardan Karamyan, Ph.D., in a recent collaborative study, continues his previous work evaluating the potential of Nln as a therapeutic target for stroke by seeking to identify small molecules capable of enhancing the activity and catalytic efficiency of Nln.

TTUHSC Technology Leads Successful Clinical Trial to Treat Dry Eye Disease

  • By Mark Hendricks
  • September 29, 2021

Hironmoy Das, Ph.D., a professor of pharmaceutical sciences at the Texas Tech University Health Sciences Center (TTUHSC) Jerry H. Hodge School of Pharmacy, developed a technology derived from corneal epithelial stem cells to improve outcomes for DED patients.

Tags